NCT06102525 2025-09-05A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With GlioblastomaRznomics, Inc.Phase 1/2 Recruiting43 enrolled
NCT00478465 2022-05-27Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)Stanford UniversityPhase 1/2 Completed30 enrolled